Overview Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis Status: Recruiting Trial end date: 2028-12-30 Target enrollment: Participant gender: Summary oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis Phase: Phase 3 Details Lead Sponsor: Tanta UniversityTreatments: CefotaximeCefoxitinGemifloxacin